marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Amneal Pharmaceuticals Cash Flow 2011-2024 | AMRX
Annual Cash Flow Amneal Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
346 M | 65.1 M | 242 M | 379 M | 1.7 M | 250 M | 234 M | 115 M | - | - | - | - | - |
Depreciation & Amortization |
66.2 M | 68.1 M | 60.7 M | 60.4 M | 63.3 M | 64.4 M | 42 M | 29.3 M | - | - | - | - | - |
Accounts Payables |
- | - | - | 153 M | 103 M | 115 M | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | 639 M | 604 M | 481 M | - | - | - | - | - | - | - |
Total Inventories |
581 M | 531 M | 489 M | 491 M | 381 M | 457 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Amneal Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -4.41 M | - | - | 140 M | - | 88.4 M | -5.18 M | 120 M | - | 179 M | 96.2 M | 148 M | - | 273 M | 228 M | 49 M | - | 52.6 M | -87.3 M | -108 M | - | -9.42 M | -71.6 M | 27 M | - | 169 M | 95.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
43.3 M | 40.1 M | 39.9 M | 40.6 M | 40.8 M | 41.1 M | - | 44.5 M | 42 M | 40.9 M | - | 43.8 M | 43.5 M | 41.7 M | - | 44.5 M | 44 M | 42.6 M | - | 38 M | 34.8 M | 31 M | - | 17.4 M | 15.5 M | 1.76 M | - | 10.7 M | 9.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
235 M | 200 M | 175 M | - | 140 M | 137 M | 166 M | - | - | - | 131 M | - | - | - | 153 M | - | - | - | 103 M | - | - | - | 115 M | 125 M | 169 M | - | 70 M | 70 M | 70 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | 546 M | 742 M | 629 M | 689 M | 538 M | 663 M | 628 M | 652 M | 531 M | 639 M | 639 M | 639 M | 639 M | 604 M | 604 M | 604 M | 604 M | 481 M | 481 M | 481 M | 481 M | 351 M | 351 M | 351 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
596 M | 576 M | 571 M | - | 551 M | 529 M | 531 M | 544 M | 533 M | 512 M | 489 M | 520 M | 523 M | 497 M | 491 M | 491 M | 491 M | 491 M | 381 M | 381 M | 381 M | 381 M | 457 M | 457 M | 457 M | 457 M | 284 M | 284 M | 284 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency